CDKN2B抗体,Rabbit Polyclonal CDKN2B Antibody
  • CDKN2B抗体,Rabbit Polyclonal CDKN2B Antibody
  • CDKN2B抗体,Rabbit Polyclonal CDKN2B Antibody
  • CDKN2B抗体,Rabbit Polyclonal CDKN2B Antibody

CDKN2B抗体;CDKN2B Antibody—艾普蒂

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-28
QQ交谈 微信洽谈

产品详情

中文名称:CDKN2B抗体英文名称:Rabbit Polyclonal CDKN2B Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 7507 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: CDKN2B
2025-05-28 CDKN2B抗体 Rabbit Polyclonal CDKN2B Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 7507 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesP15; MTS2; TP15; CDK4I; INK4B; p15INK4b
WB Predicted band size15 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human CDKN2B
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 12%SDS-PAGE, Lysate: 40 μg, Lane: 293T cell lysate, Primary antibody: P13818(CDKN2B Antibody) at dilution 1/1350, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 40 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using P13818(CDKN2B Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于CDKN2B抗体的参考文献示例(仅供参考,具体文献需通过学术数据库查询):

---

1. **文献名称**: *"CDKN2B methylation correlates with immune infiltration in acute myeloid leukemia"*

**作者**: Kim J. et al. (2018)

**摘要**: 研究通过甲基化特异性PCR和CDKN2B抗体免疫印迹,发现CDKN2B启动子高甲基化与AML患者肿瘤微环境中免疫细胞浸润减少相关,提示其表观遗传调控在白血病进展中的作用。

2. **文献名称**: *"p15INK4B expression loss in solid tumors: An immunohistochemical analysis"*

**作者**: Smith R. et al. (2020)

**摘要**: 使用抗CDKN2B(p15)抗体对多种实体瘤样本进行免疫组化分析,发现CDKN2B蛋白表达缺失与肿瘤分化程度低及预后不良显著相关,支持其作为抑癌基因的临床意义。

3. **文献名称**: *"CDKN2B regulates vascular smooth muscle cell senescence in atherosclerosis"*

**作者**: Zhang Y. et al. (2019)

**摘要**: 通过Western blot和免疫荧光(CDKN2B抗体)证实,动脉粥样硬化斑块中CDKN2B表达上调促进血管平滑肌细胞衰老,可能成为治疗靶点。

4. **文献名称**: *"Antibody-based detection of CDKN2B variants in neurodegenerative disorders"*

**作者**: Brown K. et al. (2021)

**摘要**: 开发了一种高特异性CDKN2B抗体,用于ELISA和脑组织染色,发现阿尔茨海默病患者脑脊液中CDKN2B剪切变体异常积累,提示其与神经退行性病变的潜在关联。

---

**注**:以上文献为示例,实际引用时请通过PubMed、Web of Science等平台检索真实研究,并核对作者、年份及摘要准确性。

       

背景信息

The CDKN2B antibody is a key tool for studying the cyclin-dependent kinase inhibitor 2B (CDKN2B), a protein encoded by the *CDKN2B* gene located on chromosome 9p21.3. CDKN2B, also known as p15INK4B, belongs to the INK4 family of cell cycle regulators and inhibits cyclin-dependent kinases 4 and 6 (CDK4/6), thereby blocking G1-to-S phase progression and promoting cell cycle arrest. This tumor suppressor is often epigenetically silenced or deleted in cancers, including gliomas, leukemias, and melanomas, contributing to uncontrolled proliferation. Its expression is also modulated by TGF-β signaling in growth inhibition contexts.

CDKN2B antibodies are widely used in research to detect protein expression via techniques like Western blotting, immunohistochemistry (IHC), and flow cytometry. They help investigate CDKN2B's role in diseases, such as its downregulation in tumorigenesis or its association with cardiovascular and aging-related disorders via genetic susceptibility loci. Validating antibody specificity is critical, as CDKN2B shares homology with other INK4 proteins (e.g., p16INK4A). High-quality antibodies enable studies on CDKN2B's interaction partners, post-translational modifications, and regulatory mechanisms. Clinically, CDKN2B antibodies may aid in diagnosing malignancies with 9p21 deletions or evaluating epigenetic therapies targeting DNA methylation. Overall, these antibodies are essential for unraveling CDKN2B's pathophysiological roles and therapeutic potential.

       
关键字: CDKN2B抗体;CDKN2B;CDKN2B Antibody;

公司简介

生物技术有限公司
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,植物生物技术,细胞培养,蛋白组学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:生物试剂
  • 公司地址:青浦
询盘

CDKN2B抗体;CDKN2B Antibody—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
¥960.00
VIP10年
北京索莱宝科技有限公司
2025-11-14
¥1138
VIP4年
上海沪震实业有限公司
2025-11-13
¥1800
VIP1年
费雪(杭州)医学研究有限公司
2025-11-03
询价
湖北艾普蒂生物工程有限公司
2024-02-21
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.